Year archive

EMROCK CORPORATION LIMITED — 2026 filings

All 22 regulatory filings released by EMROCK CORPORATION LIMITED (531676) in 2026, sourced directly from the official regulator.

22 Filings

2026 Period

2026 filings (22)

Filing	Released	Lang
Pursuant to Regulation 30of SEBI (LODR) Regulation, 2015, Company Published Newspaper Advertisement for the EGM in English & Gujarati Newspaper on Today 30th May 2025 Regulatory Filings	2026-05-30	English
INTIMATION OF CUT OFF DATE FOR EVOTING AT EGM Regulatory Filings	2026-05-29	English
SUBMISSION OF NOTICE OF 1ST EGM FOR F.Y 2026-27 WILL BE HELD ON 27TH JUNE 2026 Proxy Solicitation & Information Statement	2026-05-29	English
Secretarial Compliance Report for the year ended 31st March, 2026. Regulatory Filings	2026-05-28	English
The company has Appointed Mrs. Rekha Sejpal as Scrutinizer for e-voting process in ensuring EGM of the company will be held on 27th June 2026 Regulatory Filings	2026-05-28	English
The Board of Directors of the Company at their Meeting held on Today, Considered and Approved increase in Authorised Share Capital of the Company and Subsequent alteration to Clause V of .... Share Issue/Capital Change	2026-05-28	English
The Board at their Meeting held on today has considered and approved issue on convertible share warrant on preferential basis subject to the approval of members in upcoming EGM in terms .... Share Issue/Capital Change	2026-05-28	English
THE BOARD OF THE COMPANY AT THEIR MEETING HELD ON TODAY 28TH MAY 2026 HAS CONSIDERED AND APPROVED THE ITEMS AS MENTIONED IN THE ATTACHED FILE Share Issue/Capital Change	2026-05-28	English
Emrock Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Revised intimation of Board .... Regulatory Filings	2026-05-25	English
Closure of trading window from 22.05.2026 till 48 hours after declaration of outcome Regulatory Filings	2026-05-22	English
Emrock Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... Regulatory Filings	2026-05-22	English
Revised outcome , as the Independent Auditors Report was not attached inadvertently. Re-submitted outcome with Auditors Report on financials for the Quarter and Year Ended 31st March, 2026 Interim / Quarterly Report FY 2026	2026-05-22	English
In earlier announcement dated 19.05.2026 disseminated by exchange at 16:05:32 project completion date inadvertently mentioned as June 30, 2026 instead of June 30, 2027 stake holder are .... Capital/Financing Update	2026-05-19	English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Capital/Financing Update	2026-05-19	English
Intimation of incorporation of Subsidiary company M&A Activity	2026-05-15	English
Publication of Audited results in English and Gujarati newspaper Report Publication Announcement	2026-05-14	English
Strategic Expansion in to pharmaceutical sector, being one of the main object of the company, through incorporation of LLP Regulatory Filings	2026-05-12	English
Annoucement pursuant to commence of implementation of project and material procurement order of Approximate Rs. 104.52 Crores. Regulatory Filings	2026-05-12	English
Based on recommendation of Nomination and Remuneration committee Board of Directors at their meeting held on today Appointed Mr. Parth T. Patel as Whole Time Director [DIN 07289967] of the Company. Board/Management Information	2026-05-12	English
Based on recommendation of audit committee Board of Directors at their meeting held on today appointed M/s Rekha Sejpal & Associates, as a Secretarial Auditor of the company for the financial .... Regulatory Filings	2026-05-12	English
Audited Financial Result of the company for the fourth quarter and year ended on 31st March, 2026 along with the Audit Report issued by Statutory Auditor of the company. Interim / Quarterly Report FY 2026	2026-05-12	English
Intimation of Resignation of Secretarial Auditor pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Regulatory Filings	2026-05-08	English